Literature DB >> 8533657

[Dark rim around choroidal neovascularization in indocyanine green angiography].

I Fukushima1, K Takahashi, T Nishimura, H Ohkuma, M Uyama.   

Abstract

Experimentally produced choroidal neovascularization (ChNV) surrounded by a dark rim in indocyanine green (ICG) angiography was studied histopathologically. Dark rims were seen in 28% of ChNVs which were detected with ICG angiography 2 weeks after photocoagulation. During the developing stage of ChNV, the dark rim around it was seen in the early phase of ICG angiography, but in the late phase, the dark rim became unclear because of extravascular dye leakage. During the regressive stage, the dark rim was seen in all phases of angiography. It was especially clear in the late phase. Histopathologically, at the site of the dark rim the retinal pigment epithelial cells proliferated to surround the ChNV in the subretinal space during both stages. These results show that proliferated retinal pigment epithelium surrounding ChNV blocks the fluorescence of the choroid, and causes the dark rim. The dark rim is helpful for diagnosis of ChNV.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8533657

Source DB:  PubMed          Journal:  Nippon Ganka Gakkai Zasshi        ISSN: 0029-0203


  3 in total

1.  The analysis of lacquer crack in the assessment of myopic choroidal neovascularization.

Authors:  Y M Kim; J U Yoon; H J Koh
Journal:  Eye (Lond)       Date:  2011-04-29       Impact factor: 3.775

2.  Indocyanine green angiographic features of myopic subfoveal choroidal neovascularization as a prognostic factor after photodynamic therapy.

Authors:  Suk Ho Byeon; Oh Woong Kwon; Sung Chul Lee; Sung Soo Kim; Hyoung Jun Koh
Journal:  Korean J Ophthalmol       Date:  2006-03

3.  Association between choriocapillaris flow deficit and choroidal neovascularization activity in eyes with myopic choroidal neovascularization.

Authors:  Sato Uematsu; Hirokazu Sakaguchi; Kaori Sayanagi; Yasushi Ikuno; Ayako Yokoyama; Tomoko Asai; Yoko Fukushima; Chikako Hara; Susumu Sakimoto; Kohji Nishida
Journal:  Sci Rep       Date:  2021-11-09       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.